In Monday's Analysts' actions, Wall Street firms are concentrating on EMC (EMC), Salesforce (CRM), and Nordstrom (JWN). Jefferies downgraded EMC to HOLD from BUY with a $29 price target. This comes after the announcement Monday that computer maker Dell together with MSD Partners and Silver Lake will buy the data storage company for about $67 billion, making it the largest deal in tech history. Analysts said they're concerned about the size of the debt raise and that there are risks if the deal doesn't go through. In a different note, JMP Securities lifted Salesforce's price target to $90 from $84. The firm is keeping its MARKET OUTPERFORM rating on the stock. The cloud computing company has 'multiple growth avenues' and after the investor meetings last week, it appears that the company is headed in the right direction, analysts said. Moving on to the retail sector, Credit Suisse cut Nordstrom's price target to $75 from $76. The reason? Nordstrom recently completed the sale of its credit card portfolio to the Toronto-Dominion Bank (TD). The price target change reflects this action, analysts said. Overall, the retailer has a 'unique' strategic direction but for now, analysts are staying on the sidelines. The firm is keeping its NEUTRAL rating on the stock. TheStreet's U-Jin Lee reports in New York.
More from Video
Amid the Selling, Here's the Big Question Now
How quickly do we find support, is what we'll want to know now, as the correction is occurring while economic optimism builds.
One Tweet Pulls the Rug Out From Under the Indexes
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
A Technical Look at the New Dow Jones Industrial Average
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
Conagra Brands Looks Tastier After Its Upgrade to Buy
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Biogen Bulls Get a Lift From Quant Upgrade and Strengthening Charts
Breaking down an approach to the long side of this biotech stock.
Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation.
If you have questions, please contact us here.